Caxton Associates (New York)’s Cullinan Oncology CGEM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,541	Closed	-$108K	–	520
2023 Q1	$108K	Buy	+10,541	New	+$108K	0.02%	457